期刊文献+

晚期平滑肌肉瘤的二线化疗 被引量:4

下载PDF
导出
摘要 平滑肌肉瘤(leiomyosarcoma,LMS)是一种侵袭性的软组织肉瘤,目前多采用以手术切除为主的综合治疗方案。对于晚期尤其是转移性LMS患者,主要的治疗手段为系统化疗和分子靶向治疗。综合近年的研究结果,对于一线治疗失败的LMS患者,二线单药化疗可以选用吉西他滨(GEM)、达卡巴嗪(DTIC)和替莫唑胺(TMZ),联合化疗可以选用GEM联合多西他赛(TXT)或DTIC等方案。对于二线化疗失败、有化疗禁忌证或拒绝化疗者,可以尝试使用帕唑帕尼等分子靶向药物。
作者 孙元珏 姚阳
出处 《癌症进展》 2015年第1期19-23,共5页 Oncology Progress
  • 相关文献

参考文献23

  • 1Gustafson P, Willen H, Baldetrop B, et al. Soft tissue leiomyosarcoma: a population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content[J]. Cancer, 1992, 70(1): 114-119.
  • 2Weiss SW, Goldblum JR. Enzinger and Weiss' s Soft Tis- sue Tumors. 4th ed. Philadelphia: Mosby-Harcort, 2001.
  • 3Golden T, Stout AR Smooth muscle tumors of the gas- trointestinal tract and retroperitoneal tissues[J]. Surg Gy- necol Obstet, 1941, 73: 784-810.
  • 4Spira AI, Ettinger DS. The use of chemotherapy of soft tissue sarcomas[J]. Oncologist, 2002, 7(4): 348-359.
  • 5Femberg JO, Hall KS. Chemotherapyin soft tissue sarco- ma.the Scandinavian Sarcoma Group experience[J]. Acta Orthop Scand Suppl, 2004, 75(311): 77-86.
  • 6Bitz U, Pink D, Busemann C, et al. Doxorubicin (Doxo) and dacarbacin (DTIC) as first-line therapy for patients (pts) with locally advanced or metastatic leiomyosarco- ma (LMS) and liposarcoma (LPS)[J]. J Clin Oncol, 2011, 29(15 Suppl): Abstr 10094.
  • 7Look KY ,Sandler A, Blessing JA, et al. Phase Ⅱ trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma; a Gynecologic Oncology Group(GOG) Study[J]. Gynecol Oncol, 2004, 92(2): 644-647.
  • 8Ferraresi V, Ciccarese M, Cercato MC, et al. Gemcitabi- ne at fixed dose-rate in patients with advanced soft-tis- sue sarcomas: a mono-institutional phase Ⅱ study[J]. Cancer Chemother Pharmacol, 2008, 63(1): 149-155.
  • 9Losa R, Fra J, Ldpez-Pousa A, et al. Phase Ⅱ study with the combination of gemcitabine and DTIC in pa- tients with advanced soft tissue sarcomas[J]. Cancer Che- mother Pharmacol, 2007, 59(2): 251-259.
  • 10Hensley ML, Maki R, Venkatraman E, et al. Gemcitabi-ne and docetaxel in patients with unresectable leiomyo- sarcoma: results of a phase I trial[J]. J Clin Oncol, 2002, 20(1): 2824-2831.

同被引文献56

  • 1彭惠,杨光华,步宏,郭立新,王华.软组织平滑肌肉瘤3p微卫星不稳定性及其临床意义[J].临床与实验病理学杂志,2004,20(3):277-280. 被引量:1
  • 2韦敏,肖亿.替莫唑胺的临床应用进展[J].现代医药卫生,2006,22(12):1825-1826. 被引量:1
  • 3黄文权,潘恒,李冲云.少见部位平滑肌肉瘤的CT诊断(附12例分析)[J].中国医学影像学杂志,1996,4(2):109-110. 被引量:1
  • 4Vraa S, Keller J, Nielsen OS, et al. Prognostic factors in soft tissue sar- comas: the Aarhus experience. Eur J Cancer, 1998,34:1876-1882.
  • 5Kfstler WJ, Brodowicz T, Attems Y, et al. Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II triall. Ann Oncol,2001,12: 1281-1288.
  • 6look KY, Sandier A, Blessing JA, et al. Phase lI trial of gemcitabine as second-I ine chemotherapy of uterine eiomyosarcoma: a Gynecologic On- cology Group (GOG) Study. Gynecol Oncol,2004,92:644-647.
  • 7Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetax- el in patients with unresectable leiomyosarcoma: results of a phase II tri- al. J Clin Oncol, 2002, 20:2824-2831.
  • 8Leu KM, Ostnlszka LJ, Shewach D, et al. Laboratory and clinicalevi- dence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol, 2004, 22 : 1706-1712.
  • 9Maki RG, Wathen JK, Patel SR, et al. Randomized phase II study of gemcitabine and doeetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol, 2007, 25: 2755-2763.
  • 10Bay JO, Ray-Coquard I, Fayette J, et al. Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analy- sis. Int J Cancer, 2006, 119: 706-711.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部